Moolec Science (MLEC) Other Operating Expenses (2023 - 2024)
Moolec Science (MLEC) reported Other Operating Expenses of $549863.0 for Q4 2024, up 147.13% on a YoY basis from $222496.2 in Q1 2024, and up 11.11% sequentially from $494902.0 in Q3 2024.
Moolec Science (MLEC) Other Operating Expenses (2023 - 2024) Analysis & Trends
Moolec Science (MLEC) has 2 years of Other Operating Expenses data on file, last reported at $549863.0 in Q4 2024.
- For the quarter ending Q4 2024, Other Operating Expenses rose 147.13% year-over-year to $549863.0; the trailing twelve-month figure through Mar 2026 stood at $549863.0 (changed N/A YoY), and the FY2024 full-year result was -$703265.0, down 166.64% from the prior year.
- Other Operating Expenses climbed to $549863.0 in Q4 2024, from $494902.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $4.2 million in Q3 2023 to a low of -$6.6 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 549,863.00 |
| Sep 30, 2024 | 494,902.00 |
| Mar 31, 2024 | -6.65 Mn |
| Dec 31, 2023 | -1.17 Mn |
| Sep 30, 2023 | 4.18 Mn |
| Mar 31, 2023 | -1.12 Mn |